Google
Trusted Resources: Community Center
Online support, community stories, financial assistance
Discoveries in CAEL-101 Trial for Patients With AL Amyloidosis
Jason Valent, MD, Director of the Multiple Myeloma Program and Co-Director of the Amyloidosis Program at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the developments of the CAEL-101 trial for patients with AL amyloidosis. Listen as Dr. Valent talks about the discoveries and changes in treatment in each phase of the trial.
myBinderRelated Content
-
Sally Arai, MDDr. Arai is an Associate Professor of Me...
-
Julia Platt, MS, LCGCJulia earned her MS in Genetic Counselin...
-
Q&A: Fatigue, Amyloid Presence in Bone Marrow, CAR-T – ASG Webinar 13/13https://www.youtube.com/watch?v=4gUXPbOk...
-
Left Ventricular Myocardial Deformation on Cine MR Images: Relationship to Severity of Disease and Prognosis in Ligh...Purpose: To measure left ventricular (L...
-
Pulmonary Nodular Amyloidosis Mimicking Metastatic Lung Lesion in a Patient with Colon CancerAmyloidosis is defined as abnormal aggre...
-
ATTR in the Heart – ASG Webinar 1/7https://www.youtube.com/watch?v=IzC_yaqs...
-
Webinar Presentation by Heather J. Landau on Light Chain (AL) Amyloidosishttps://www.youtube.com/watch?v=hOCrAsld...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
